We are live on
!
Find out more
RJT
Raymond James Trust Portfolio holdings
AUM
$4.6B
1-Year Est. Return
33.54%
This Fund
S&P 500
This Quarter
Est. Return
+13.8%
1 Year Est. Return
+33.54%
3 Year Est. Return
+41.33%
5 Year Est. Return
+111.23%
10 Year Est. Return
+235.1%
AUM
$2.61B
AUM Growth
+$292M
(+13%)
Cap. Flow
+$4.3M
Cap. Flow
% of AUM
0.16%
Top 10 Holdings %
Top 10 Hldgs %
19.76%
Holding
1,079
New
101
Increased
398
Reduced
436
Closed
41
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.25M |
| 2 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$5.72M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$4.25M |
| 4 |
Aflac
AFL
|
+$3.07M |
| 5 |
General Mills
GIS
|
+$2.99M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fulgent Genetics
FLGT
|
+$37.7M |
| 2 |
Raymond James Financial
RJF
|
+$17.5M |
| 3 |
Pfizer
PFE
|
+$2.41M |
| 4 |
Apple
AAPL
|
+$2.29M |
| 5 |
Vanguard High Dividend Yield ETF
VYM
|
+$2.11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.48% |
| 2 | Healthcare | 10.65% |
| 3 | Financials | 10.27% |
| 4 | Consumer Staples | 8.1% |
| 5 | Industrials | 6.85% |
Similar funds
ECU
SI
WPL
FPCG
PWLP
CAC
SA
CIP
Raymond James Trust's Q4 2020 Portfolio in Review
As of Q4 2020, Raymond James Trust held 1,079 positions worth $2.61B, up 13% from $2.32B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Raymond James Trust's Q4 2020 filing shows 101 new, 398 increased, 436 reduced and 41 closed positions. Its largest new stake was Invesco S&P 500 Pure Value ETF: 22,191 shares worth $1.36M. The largest sale was Fulgent Genetics, an estimated $37.7M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
- Raymond James Trust's largest Q4 2020 buy was Invesco S&P 500 Pure Value ETF: 22,191 shares worth $1.36M.
- Raymond James Trust added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $6.25M increase.
- Raymond James Trust's biggest Q4 2020 reduction was Fulgent Genetics, cutting an estimated $37.7M.
- Raymond James Trust fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $981K.
- Raymond James Trust's ten largest holdings make up 20% of its $2.61B portfolio in Q4 2020.
- Raymond James Trust opened 101 new positions and closed 41 in Q4 2020.
- Raymond James Trust's portfolio value rose 13% quarter-over-quarter to $2.61B.
Based on Raymond James Trust's 13F filing for Q4 2020, filed 13 Jan 2021.